Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Diagnosis of primary aldosteronism in a patient with an incidentally found adrenal mass

Abstract

Background A 50-year-old woman who was complaining of abdominal pain was referred to the endocrine clinic after a small (0.8 cm by 0.8 cm) mass was found in her right adrenal gland on CT examination of the abdomen. She had a history of hypertension for 10 years, generalized anxiety disorder for 5 years and a weight increase of 18 kg over the previous 3 years. The patient did not report weakness, polyuria or excessive thirst. She had a history of hypokalemia while on hydrochlorothiazide therapy. To improve blood pressure control, a total of three antihypertensive medications had been sequentially added to her regimen. At presentation, medications included 300 mg irbesartan daily, 5 mg amlodipine daily and 100 mg sustained-release metoprolol daily.

Investigations Renin activity, levels of plasma aldosterone and levels of fractionated plasma metanephrines were measured and an overnight 1 mg dexamethasone suppression test was performed. In addition, measurements of urine aldosterone excretion on a high-salt diet, MRI-examination of the adrenal glands and bilateral adrenal vein sampling were conducted.

Diagnosis An aldosterone-secreting adrenal adenoma.

Management The patient underwent laparoscopic resection of the right adrenal gland, which led to normalization of aldosterone excretion, lowering of her blood pressure on a single antihypertensive medication (50 mg sustained-release metoprolol daily) and resolution of hypokalemia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: CT scan of the abdomen, obtained after administration of oral and intravenous contrast material
Figure 2: MRI scans of the abdomen in coronal (A) and axial (B, C) planes, respectively

References

  1. Grumbach MM et al. (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138: 424–429

    Article  Google Scholar 

  2. Young WF Jr (2007) Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356: 601–610

    Article  CAS  Google Scholar 

  3. Gordon RD et al. (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21: 315–318

    Article  CAS  Google Scholar 

  4. Mulatero P et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045–1050

    Article  CAS  Google Scholar 

  5. Conn JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3–17

    CAS  PubMed  Google Scholar 

  6. Ganguly A (1998) Primary aldosteronism. N Engl J Med 339: 1828–1834

    Article  CAS  Google Scholar 

  7. Weinberger MH et al. (1979) Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med 90: 386–395

    Article  CAS  Google Scholar 

  8. Connell JM and Davies E (2005) The new biology of aldosterone. J Endocrinol 186: 1–20

    Article  CAS  Google Scholar 

  9. Litchfield WR et al. (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31: 445–450

    Article  CAS  Google Scholar 

  10. Milliez P et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243–1248

    Article  CAS  Google Scholar 

  11. Montori VM and Young WF Jr (2002) Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 31: 619–632

    Article  CAS  Google Scholar 

  12. Stowasser M and Gordon RD (2001) Familial hyperaldosteronism. J Steroid Biochem Mol Biol 78: 215–229

    Article  CAS  Google Scholar 

  13. Stowasser M and Gordon RD (2003) Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 17: 591–605

    Article  CAS  Google Scholar 

  14. Lifton RP et al. (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262–265

    Article  CAS  Google Scholar 

  15. Magill SB et al. (2001) Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86: 1066–1071

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas A Tritos.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tritos, N. Diagnosis of primary aldosteronism in a patient with an incidentally found adrenal mass. Nat Rev Endocrinol 3, 547–551 (2007). https://doi.org/10.1038/ncpendmet0553

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0553

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing